published the results of a phase 3 clinical trial of tirzepatide, a dual GIP and GLP-1 receptor agonist, in patients with T2DM, showing significant results in glycemic control and weight loss (Rosenstock et al., 2021)
Diet and Exercise Habits GLPs work best when combined with: Protein-rich diets Moderate physical activity Reduced sugar and processed food intake 4
Multiple cardiovascular outcomes trials (CVOTs) have shown significant reductions in major adverse cardiovascular events (MACE), which typically includes cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke
GLP-1 Trends GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management
For global teams, Benepass advises on compliant weight health program design and administration across regions, helping employers apply a consistent strategy without losing local control
The decision to transition often reflects growing confidence in supplement use combined with ambitious wellness goals that require more sophisticated nutritional support
